A colorful chain of DNA is broken by a bright spark of light in the center

Community Spotlight: Laurie’s Experience with CAR T-Cell Therapy

Editor's note: Blood-Cancer.com recently sat down with Laurie Adami, who received numerous treatments for her stage IV follicular lymphoma, before having undergone CAR T-cell therapy.

Tell us a little bit about yourself and your blood cancer journey.

I was diagnosed in 2006 with stage IV follicular non-Hodgkin lymphoma, an incurable malignacy. At the time, I was 46 years old, the President of a financial software company and I had a young son who was in kindergarten. Over the next 12 years, I was continuously in treatment and unfortunately unable to achieve a complete remission from any of the treatments until treatment number 7, CAR T-cell therapy. The best I achieved prior to CAR T was stable disease. My 6 treatments before CAR T were R-CHOP; Phase II trial of R-Vorinostat; R-Bendamustine; Bexxar; Phase I trial of R-Idelalisib (Zydelig); and Gazyva.

You went through an extensive number of treatments. What ultimately led you to participate in a CAR T-cell therapy clinical trial?

I first heard about CAR T in 2012 and told my oncologist that he needed to keep me alive until CAR T was available for my disease. I was struck by how elegant it was that CAR T would use my own immune system to defeat my cancer, as opposed to the manmade agents I had previously received. By 2018, I had exhausted all of the available options and had a rapidly advancing disease which had infiltrated my kidneys. It was estimated I had over 8 pounds of cancer tumors. Just in time, I was informed by my oncologist that a Phase II CAR T trial was opening for follicular NHL. I would be one of five patients in the cohort at UCLA and would be the first to participate.

What was the CAR T-cell therapy procedure like for you?

Going into the hospital to get my CAR T-cells back, I knew that I was at high risk for side effects as a result of the bulkiness of my disease. I was also out of options and really had no other choice. I felt great confidence in the way CAR T works. Ultimately CAR T was successful for me and I remain in complete remission two years after receiving my CAR T-cells back.

Did you have any side effects from CAR T-cell therapy? How did they compare to the side effects from the other treatments?

The side effects for CAR T can include cytokine release syndrome (CRS) and neurological issues. Before I went in to get my genetically modified CAR T-cells back, I had spoken to several people who had previously had CAR T. The only side effects they reported to me were fevers and a little mental confusion. Unfortunately, that was not my experience and I had grade IV CRS as well as brain seizures and I was placed in a medically induced coma for over a week. Oncologists believe my side effect severity resulted from the bulkiness of my disease. In the 2 years since I participated in the trial, there are several new medications that are used upfront to minimize or eliminate the side effects I experienced and in some cases, CAR T is being delivered in an outpatient setting.

The side effects I experienced after CAR T were thankfully short-lived and I don’t seem to have any long term side effects. I had a variety of side effects from the six previous therapies I had and sadly, some have been long term.

What advice you would give someone who is considering CAR T-cell therapy as a possible treatment route?

I would encourage people to read about CAR T and speak to their oncologists. It is currently approved for 3 blood cancers: acute lymphoblastic leukemia (ALL), diffuse large B cell lymphoma (DLBCL), and mantle cell lymphoma, but there are dozens of trials for all kinds of other blood cancers taking place all over the world. CAR T for solid tumor cancers is also undergoing research.

Any other comments, tips, or words of wisdom you would like to share?

I would encourage all patients to be as patient active as they can be to seek out CAR T and see if they are a candidate for it. I wish it had been available for me earlier in my cancer journey as I could have eliminated the cancer without going through the other heavy-duty treatments I experienced.

By providing your email address, you are agreeing to our privacy policy. We never sell or share your email address.

This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The Blood-Cancer.com team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.

Join the conversation

or create an account to comment.